Pharmaceutical News and Articles

September is Peak Asthma Month: Is Your Child Ready?

especially in children. But there are ways parents can help their kids keep their allergy and asthma symptoms at bay as the school year resumes, Marshall said.F

Summer's Heat Can Damage Your Medicines: Keep Them Safe

As scorching temperatures continue to plague the United States this summer, millions of Americans are at risk for dehydration and heat-linked illness.But what a

Disparities Seen in Unintentional Firearm Mortality Across U.S. States

There are considerable disparities in the rate of unintentional firearms mortality across the 50 U.S. states and District of Columbia, with the highest rates cl

Gynecology-Related Internet Searches Up Following Release of Barbie Movie

The closing line of the movie Barbie ( I m here to see my gynecologist ) may have spurred public interest in gynecology, according to a research letter publishe

Study Examines Impact of Unintended Pregnancy Among Active-Duty Soldiers

Estimates of unintended pregnancy (UIP) among active-duty service women (ADSW) indicate a considerable impact on the ability to meet Women, Peace, and Security

Kids From Poorer Families Less Likely to Survive Cancer

Children from poor families are less likely to survive cancer, particularly if they are not white, a new study reports. A childhood cancer patient s risk of dyi

Boar's Head Recalls Liverwurst Tied to Listeria Outbreak

Boar s Head announced Friday that it was recalling all of its liverwurst products because they could be tainted with dangerous Listeria monocytogenes bacteria.

Prostate Cancer Outcomes Comparable for Transgender Women, Cisgender Men

Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate cancer-specific mortality,

Wildfires Are Creating Hazardous Air Conditions in Western North America

Wildfires raging across the western parts of the United States and Canada are prompting air quality alerts and evacuation orders. Smoke and haze have filled the

FDA Approves Leqselvi (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata